Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22323923a6c68a314cce4e8eab26fe79 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 |
filingDate |
2014-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba6019a7ee561b4f1a8f8f3c59c0dd1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa355d331e333327a492fc836a89924e |
publicationDate |
2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014179738-A1 |
titleOfInvention |
Methods for the treatment of cancer |
abstract |
Described herein are methods for the treatment of cancer in a subject. In particular, methods are provided for the treatment of lung cancer with a combination of entinostat and an EGFR inhibitor, or the treatment of breast cancer with a combination of entinostat and an aromatase inhibitor. Furthermore, a food effect was evident for the oral administration of entinostat. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107921108-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3313433-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3487492-A4 |
priorityDate |
2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |